Explore
Validate
LearnABIN151858
antibody from antibodies-online
Targeting: TCF3
bHLHb21, E2A, E47, ITF1, MGC129647, MGC129648, p75, VDIR
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN151858 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Transcription Factor 3 (E2A Immunoglobulin Enhancer Binding Factors E12/E47) (TCF3) (pThr355) antibody
- Antibody type
- Polyclonal
- Description
- Immunogen affinity purified
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- pThr355
- Vial size
- 100 μL
- Storage
- Store at 4°C. Do not freeze.
- Handling
- Do not freeze.
Submitted references Accelerated Notch-dependent degradation of E47 proteins in aged B cell precursors is associated with increased ERK MAPK activation.
Positive regulation of myogenic bHLH factors and skeletal muscle development by the cell surface receptor CDO.
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
King AM, Van der Put E, Blomberg BB, Riley RL
Journal of immunology (Baltimore, Md. : 1950) 2007 Mar 15;178(6):3521-9
Journal of immunology (Baltimore, Md. : 1950) 2007 Mar 15;178(6):3521-9
Positive regulation of myogenic bHLH factors and skeletal muscle development by the cell surface receptor CDO.
Cole F, Zhang W, Geyra A, Kang JS, Krauss RS
Developmental cell 2004 Dec;7(6):843-54
Developmental cell 2004 Dec;7(6):843-54
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities.
Nie L, Xu M, Vladimirova A, Sun XH
The EMBO journal 2003 Nov 3;22(21):5780-92
The EMBO journal 2003 Nov 3;22(21):5780-92
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
